Outcome After Procedures for Retained Blood Syndrome in Coronary SurgeryPaul Molloy
OBJECTIVES:
Incomplete drainage of blood from around the heart and lungs can lead to retained blood syndrome (RBS) after cardiac sur-
gery. The aim of this study was to assess the incidence of and the outcome after procedures for RBS in patients undergoing isolated coronary artery bypass grafting (CABG)-
ERAS Cardiac Surgery Recommends Active Maintenance of Chest Tube Patency (Class I, Level B-NR) and the only FDA cleared device indicated to do so is the ~ PleuraFlow® Active Clearance Technology® System
ERAS CARDIAC surgery symposium is about to begin at AATS2018 in San Diego, CA. This groundbreaking session will be vital in improving patient outcomes in cardiac surgery, thanks to the efforts of its members. Enhanced Recovery
AATS ERAS 2018 Symposium Agenda ~ ~ Special Cardiac Surgery Session: Enhance...Paul Molloy
Association for Thoracic Surgery (AATS) 98th Annual Meeting ~ 4/28 - 5/1 ~ San Diego ~ Special Cardiac Surgery Session: Enhanced Recovery After Surgery (ERAS®)
Dr. Louis P. Perrault, Institute of Cardiologie de Montreal, will be leading a discussion on Enhanced Recovery After Cardiac Surgery ~ "Modern Chest Tube Strategies to Reduce Complications and Costs." ~ http://bit.ly/2ErFxgB
AATS ERAS 2018 Symposium Invitation ~ Special Cardiac Surgery Session: Enhanc...Paul Molloy
Association for Thoracic Surgery (AATS) 98th Annual Meeting ~ 4/28 - 5/1 ~ San Diego ~ Special Cardiac Surgery Session: Enhanced Recovery After Surgery (ERAS®)
Dr. Louis P. Perrault, Institute of Cardiologie de Montreal, will be leading a discussion on Enhanced Recovery After Cardiac Surgery ~ "Modern Chest Tube Strategies to Reduce Complications and Costs." ~ http://bit.ly/2ErFxgB
Pericardial Blood as a Trigger for POAF Affter Cardiac Surgery ~ Annals of Th...Paul Molloy
Background. Prevention strategies have long been
sought to reduce the incidence and burden of postoperative
atrial fibrillation (POAF) after heart surgery.
However, none has emerged as a dominant and widely
applicable prophylactic measure. The purpose of this
review is to consider the biological mechanisms by which
shed mediastinal blood leads to oxidation and inflammation
within the postoperative pericardial environment
and how this might trigger POAF in susceptible persons,
.....
Value Analysis Committee Presentation (Branded) - PleuraFlow® ACT® SystemPaul Molloy
Presentation explaining how the PleuraFlow® ACT® System from ClearFlow,Inc.can Reduce Complications and Costs for your Cardiothoracic surgery patients.
Value Analysis Committee Presentation - PleuraFlow® ACT® SystemPaul Molloy
Presentation explaining how the PleuraFlow® ACT® System from ClearFlow,Inc.can Reduce Complications and Costs for your Cardiothoracic surgery patients.
Outcome After Procedures for Retained Blood Syndrome in Coronary SurgeryPaul Molloy
OBJECTIVES:
Incomplete drainage of blood from around the heart and lungs can lead to retained blood syndrome (RBS) after cardiac sur-
gery. The aim of this study was to assess the incidence of and the outcome after procedures for RBS in patients undergoing isolated coronary artery bypass grafting (CABG)-
ERAS Cardiac Surgery Recommends Active Maintenance of Chest Tube Patency (Class I, Level B-NR) and the only FDA cleared device indicated to do so is the ~ PleuraFlow® Active Clearance Technology® System
ERAS CARDIAC surgery symposium is about to begin at AATS2018 in San Diego, CA. This groundbreaking session will be vital in improving patient outcomes in cardiac surgery, thanks to the efforts of its members. Enhanced Recovery
AATS ERAS 2018 Symposium Agenda ~ ~ Special Cardiac Surgery Session: Enhance...Paul Molloy
Association for Thoracic Surgery (AATS) 98th Annual Meeting ~ 4/28 - 5/1 ~ San Diego ~ Special Cardiac Surgery Session: Enhanced Recovery After Surgery (ERAS®)
Dr. Louis P. Perrault, Institute of Cardiologie de Montreal, will be leading a discussion on Enhanced Recovery After Cardiac Surgery ~ "Modern Chest Tube Strategies to Reduce Complications and Costs." ~ http://bit.ly/2ErFxgB
AATS ERAS 2018 Symposium Invitation ~ Special Cardiac Surgery Session: Enhanc...Paul Molloy
Association for Thoracic Surgery (AATS) 98th Annual Meeting ~ 4/28 - 5/1 ~ San Diego ~ Special Cardiac Surgery Session: Enhanced Recovery After Surgery (ERAS®)
Dr. Louis P. Perrault, Institute of Cardiologie de Montreal, will be leading a discussion on Enhanced Recovery After Cardiac Surgery ~ "Modern Chest Tube Strategies to Reduce Complications and Costs." ~ http://bit.ly/2ErFxgB
Pericardial Blood as a Trigger for POAF Affter Cardiac Surgery ~ Annals of Th...Paul Molloy
Background. Prevention strategies have long been
sought to reduce the incidence and burden of postoperative
atrial fibrillation (POAF) after heart surgery.
However, none has emerged as a dominant and widely
applicable prophylactic measure. The purpose of this
review is to consider the biological mechanisms by which
shed mediastinal blood leads to oxidation and inflammation
within the postoperative pericardial environment
and how this might trigger POAF in susceptible persons,
.....
Value Analysis Committee Presentation (Branded) - PleuraFlow® ACT® SystemPaul Molloy
Presentation explaining how the PleuraFlow® ACT® System from ClearFlow,Inc.can Reduce Complications and Costs for your Cardiothoracic surgery patients.
Value Analysis Committee Presentation - PleuraFlow® ACT® SystemPaul Molloy
Presentation explaining how the PleuraFlow® ACT® System from ClearFlow,Inc.can Reduce Complications and Costs for your Cardiothoracic surgery patients.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
